We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
We've found
17,797
archived clinical trials in
Peripheral Vascular Disease
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Updated: 4/27/2007
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
RESTORE-IT-Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients With a History of Atherosclerotic Disease
Updated: 4/27/2007
Randomized Evaluation of Short-Term Rifalazil Treatment on Carotid Atherosclerosis and Intima Media Thickness
Status: Enrolling
Updated: 4/27/2007
Click here to add this to my saved trials
Use of Beta Blockers in Elderly Trauma Patients
Updated: 5/9/2007
"Effects of Beta-Blockade on Cardiovascular Morbidity and Mortality in Elderly Trauma Patients: A Prospective Randomized Clinical Trial"
Status: Enrolling
Updated: 5/9/2007
Use of Beta Blockers in Elderly Trauma Patients
Updated: 5/9/2007
"Effects of Beta-Blockade on Cardiovascular Morbidity and Mortality in Elderly Trauma Patients: A Prospective Randomized Clinical Trial"
Status: Enrolling
Updated: 5/9/2007
Click here to add this to my saved trials
Retrospective Study of the Impact of Drug Eluting Stents
Updated: 8/1/2007
Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
Status: Enrolling
Updated: 8/1/2007
Retrospective Study of the Impact of Drug Eluting Stents
Updated: 8/1/2007
Retrospective Study of the Impact of Drug Eluting Stents on Intermediate Term Survival, Cardiovascular Outcomes Including Revascularization, Bleeding Rates and Economic Costs
Status: Enrolling
Updated: 8/1/2007
Click here to add this to my saved trials
Study to Evaluate the Safety and Performance of the Xpert(TM) Stent in Treating Below-the-Knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic Critical Limb Ischemia
Updated: 10/4/2007
Phase 1 Study of Xpert(TM) Nitinol Stenting for Critically Ischemic Lower Limbs
Status: Enrolling
Updated: 10/4/2007
Study to Evaluate the Safety and Performance of the Xpert(TM) Stent in Treating Below-the-Knee Lesions in Patients Undergoing Percutaneous Intervention for Chronic Critical Limb Ischemia
Updated: 10/4/2007
Phase 1 Study of Xpert(TM) Nitinol Stenting for Critically Ischemic Lower Limbs
Status: Enrolling
Updated: 10/4/2007
Click here to add this to my saved trials
The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
Updated: 11/2/2007
The Use of Magnesium to Improve Hemodynamics, Cholesterol, and Glucose Control: A Substudy of AdMag
Status: Enrolling
Updated: 11/2/2007
The Use of Magnesium to Improve Blood Pressure, Cholesterol, and Glucose Control
Updated: 11/2/2007
The Use of Magnesium to Improve Hemodynamics, Cholesterol, and Glucose Control: A Substudy of AdMag
Status: Enrolling
Updated: 11/2/2007
Click here to add this to my saved trials
Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest
Updated: 3/6/2008
Home Automatic External Defibrillator Trial -- HAT
Status: Enrolling
Updated: 3/6/2008
Home Use of Automatic External Defibrillators to Treat Sudden Cardiac Arrest
Updated: 3/6/2008
Home Automatic External Defibrillator Trial -- HAT
Status: Enrolling
Updated: 3/6/2008
Click here to add this to my saved trials
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Updated: 3/10/2008
Impact of Pre-Treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial.
Status: Enrolling
Updated: 3/10/2008
Role of Plavix in Hemorrhagic and Ischemic Complications of Catheterization.
Updated: 3/10/2008
Impact of Pre-Treatment With 600mg of Clopidogrel (Plavix) on the Incidence of Ischemic and Hemorrhagic Complications in Patients Undergoing Elective Percutaneous Coronary Revascularization.--Prospective Randomized Trial.
Status: Enrolling
Updated: 3/10/2008
Click here to add this to my saved trials
Assessment of Coronary Artery Disease by Hybrid PET/CT
Updated: 4/16/2008
Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies
Status: Enrolling
Updated: 4/16/2008
Assessment of Coronary Artery Disease by Hybrid PET/CT
Updated: 4/16/2008
Assessment of Coronary Flow Reserve and CT Angiography By Hybrid PET/CT: Relation to Clinically Indicated SPECT Studies
Status: Enrolling
Updated: 4/16/2008
Click here to add this to my saved trials
Lovaza's Effect on the Activation of Platelets
Updated: 4/23/2008
Effect of the Omega n3 Fatty on Human Platelet Function
Status: Enrolling
Updated: 4/23/2008
Lovaza's Effect on the Activation of Platelets
Updated: 4/23/2008
Effect of the Omega n3 Fatty on Human Platelet Function
Status: Enrolling
Updated: 4/23/2008
Click here to add this to my saved trials
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Updated: 5/28/2008
The Role of MMP-9 and MMP-2 in Risk Stratification for VT/VF in Patients With Implanted Cardioverter Defibrillator Devices.
Status: Enrolling
Updated: 5/28/2008
Extracellular Matrix Marker of Arrhythmia Risk (EMMA)
Updated: 5/28/2008
The Role of MMP-9 and MMP-2 in Risk Stratification for VT/VF in Patients With Implanted Cardioverter Defibrillator Devices.
Status: Enrolling
Updated: 5/28/2008
Click here to add this to my saved trials
Beta-Blocker Before Extubation
Updated: 7/22/2008
Use of Prophylactic Beta Blockade to Prevent Peri-Extubation Cardiac Ischemia and Congestive Heart Failure
Status: Enrolling
Updated: 7/22/2008
Beta-Blocker Before Extubation
Updated: 7/22/2008
Use of Prophylactic Beta Blockade to Prevent Peri-Extubation Cardiac Ischemia and Congestive Heart Failure
Status: Enrolling
Updated: 7/22/2008
Click here to add this to my saved trials
Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns
Updated: 7/29/2008
Reducing ETS Exposure of Pregnant Women and Newborns
Status: Enrolling
Updated: 7/29/2008
Tailored Videos to Reduce Tobacco Smoke Exposure Among Pregnant Women and Newborns
Updated: 7/29/2008
Reducing ETS Exposure of Pregnant Women and Newborns
Status: Enrolling
Updated: 7/29/2008
Click here to add this to my saved trials
A Web-Based Cardiovascular Intervention for the Workplace
Updated: 9/26/2008
Fast Track Program to Create a Web-Based Cardiovascular Intervention for the Workplace
Status: Enrolling
Updated: 9/26/2008
A Web-Based Cardiovascular Intervention for the Workplace
Updated: 9/26/2008
Fast Track Program to Create a Web-Based Cardiovascular Intervention for the Workplace
Status: Enrolling
Updated: 9/26/2008
Click here to add this to my saved trials
Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test
Updated: 1/14/2009
Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test
Status: Enrolling
Updated: 1/14/2009
Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test
Updated: 1/14/2009
Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test
Status: Enrolling
Updated: 1/14/2009
Click here to add this to my saved trials
United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study
Updated: 2/3/2009
United States CABG Diabetes Project (USCDP) Pilot Study
Status: Enrolling
Updated: 2/3/2009
United States Coronary Artery Bypass Surgery (CABG) Diabetes Project (USCDP) Pilot Study
Updated: 2/3/2009
United States CABG Diabetes Project (USCDP) Pilot Study
Status: Enrolling
Updated: 2/3/2009
Click here to add this to my saved trials
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Updated: 2/10/2009
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Status: Enrolling
Updated: 2/10/2009
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Updated: 2/10/2009
Ranibizumab Supplementing Panretinal Photocoagulation as Treatment for Iris/Angle Neovascularization in Retinal Ischemic Disease
Status: Enrolling
Updated: 2/10/2009
Click here to add this to my saved trials
Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG)
Status: Enrolling
Updated: 3/5/2009
Updated: 3/5/2009
Time Based Strategy to Reduce Clopidogrel Associated Bleeding Related to Coronary Artery Bypass Graft (CABG)
Status: Enrolling
Updated: 3/5/2009
Updated: 3/5/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Updated: 3/18/2009
Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents
Status: Enrolling
Updated: 3/18/2009
Click here to add this to my saved trials
Blood Pressure Control in African Americans
Updated: 4/14/2009
Multi-Site Randomized Controlled Trial for Blood Pressure Control in Hypertensive African Americans
Status: Enrolling
Updated: 4/14/2009
Blood Pressure Control in African Americans
Updated: 4/14/2009
Multi-Site Randomized Controlled Trial for Blood Pressure Control in Hypertensive African Americans
Status: Enrolling
Updated: 4/14/2009
Click here to add this to my saved trials
Hyperspectral Imaging Pre and Post Endovascular Intervention
Updated: 6/2/2009
Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).
Status: Enrolling
Updated: 6/2/2009
Hyperspectral Imaging Pre and Post Endovascular Intervention
Updated: 6/2/2009
Evaluation of the Success of Endovascular Peripheral Revascularization for the Treatment of Chronic Limb Ischemia by Measuring OxyHb and DeoxyHb Using a New Hyperspectral Imaging Device (OxyVu).
Status: Enrolling
Updated: 6/2/2009
Click here to add this to my saved trials
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
Click here to add this to my saved trials
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
Click here to add this to my saved trials
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
Click here to add this to my saved trials
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
VIVID - Valvular and Ventricular Improvement Via iCoapsys Delivery - Feasibility Study
Updated: 6/23/2009
Valvular and Ventricular Improvement Via iCoapsys Delivery (VIVID) Feasibility Study
Status: Enrolling
Updated: 6/23/2009
Click here to add this to my saved trials
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease
Updated: 7/8/2009
CCRC: Understanding the Effects of Omega-3 Fatty Acids vs. Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease.
Status: Enrolling
Updated: 7/8/2009
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease
Updated: 7/8/2009
CCRC: Understanding the Effects of Omega-3 Fatty Acids vs. Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease.
Status: Enrolling
Updated: 7/8/2009
Click here to add this to my saved trials
Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)
Updated: 7/10/2009
Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)
Status: Enrolling
Updated: 7/10/2009
Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)
Updated: 7/10/2009
Future Revascularization Evaluation in Patients With Diabetes Mellitus: Optimal Management of Multivessel Disease (FREEDOM)
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Updated: 7/10/2009
Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Status: Enrolling
Updated: 7/10/2009
Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Updated: 7/10/2009
Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Varying Characteristics of Atherogenesis and Cardiopulmonary Bypass Inflammatory Response
Updated: 7/10/2009
Phenotypic Variation in Atherogenesis and the Inflammatory Response to Cardiopulmonary Bypass
Status: Enrolling
Updated: 7/10/2009
Varying Characteristics of Atherogenesis and Cardiopulmonary Bypass Inflammatory Response
Updated: 7/10/2009
Phenotypic Variation in Atherogenesis and the Inflammatory Response to Cardiopulmonary Bypass
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
Updated: 7/10/2009
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Status: Enrolling
Updated: 7/10/2009
Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases
Updated: 7/10/2009
Enhanced Continuity of Pharmacy Care for Cardiovascular or Pulmonary Diseases
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])
Updated: 7/10/2009
Low CV Risk, Ages 25-44 & CV/Non-CV Outcomes, Ages 65+
Status: Enrolling
Updated: 7/10/2009
Examining How Heart Disease Risk Factors Affect Healthy Aging (The Chicago Healthy Aging Study [CHAS])
Updated: 7/10/2009
Low CV Risk, Ages 25-44 & CV/Non-CV Outcomes, Ages 65+
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Increasing Physical Activity Among Mexican American Women (The Enlace Study)
Updated: 7/10/2009
Enlace: A Partnership to Promote Physical Activity Among Mexican Immigrant Women
Status: Enrolling
Updated: 7/10/2009
Increasing Physical Activity Among Mexican American Women (The Enlace Study)
Updated: 7/10/2009
Enlace: A Partnership to Promote Physical Activity Among Mexican Immigrant Women
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Increasing Physical Activity Among Mexican American Women (The Enlace Study)
Updated: 7/10/2009
Enlace: A Partnership to Promote Physical Activity Among Mexican Immigrant Women
Status: Enrolling
Updated: 7/10/2009
Increasing Physical Activity Among Mexican American Women (The Enlace Study)
Updated: 7/10/2009
Enlace: A Partnership to Promote Physical Activity Among Mexican Immigrant Women
Status: Enrolling
Updated: 7/10/2009
Click here to add this to my saved trials
Polestriding Versus Walking for Subjects With Poor Leg Circulation
Updated: 7/13/2009
Polestriding Versus Walking for PAD Rehabilitation
Status: Enrolling
Updated: 7/13/2009
Polestriding Versus Walking for Subjects With Poor Leg Circulation
Updated: 7/13/2009
Polestriding Versus Walking for PAD Rehabilitation
Status: Enrolling
Updated: 7/13/2009
Click here to add this to my saved trials
Polestriding Versus Walking for Subjects With Poor Leg Circulation
Updated: 7/13/2009
Polestriding Versus Walking for PAD Rehabilitation
Status: Enrolling
Updated: 7/13/2009
Polestriding Versus Walking for Subjects With Poor Leg Circulation
Updated: 7/13/2009
Polestriding Versus Walking for PAD Rehabilitation
Status: Enrolling
Updated: 7/13/2009
Click here to add this to my saved trials
Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes
Updated: 8/10/2009
Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes: A Novel Intervention for a High Risk Population
Status: Enrolling
Updated: 8/10/2009
Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes
Updated: 8/10/2009
Effects of Pistachios on Cardiovascular Responses to Stress in Type 2 Diabetes: A Novel Intervention for a High Risk Population
Status: Enrolling
Updated: 8/10/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Aldosterone Antagonist Therapy for Adults With Heart Failure and Preserved Systolic Function
Updated: 10/6/2009
Trial of Aldosterone Antagonist Therapy in Adults With Preserved Ejection Fraction Congestive Heart Failure (TOPCAT)
Status: Enrolling
Updated: 10/6/2009
Click here to add this to my saved trials